G1 Therapeutics Inc (GTHX) Insider Trading
- $18,200,044.00
- $65,822,478.99
- March 18, 2024
- Mark A Velleca
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 18, 2024 | CFO | 6,547 | $3.02 | Sell | $19,771.94 | |
Feb. 12, 2024 | Insider | 28,600 | $4.62 | Sell | $132,132.00 | |
Jan. 4, 2024 | COO | 721 | $2.94 | Sell | $2,119.74 | |
Jan. 4, 2024 | CFO | 111 | $2.94 | Sell | $326.34 | |
Jan. 3, 2024 | Insider | 3,019 | $3.12 | Sell | $9,419.28 | |
Jan. 2, 2024 | CEO | 32,983 | $3.27 | Sell | $107,854.41 | |
Dec. 11, 2023 | Insider | 33,839 | $3.41 | Sell | $115,390.99 | |
July 5, 2023 | COO | 1,361 | $2.45 | Sell | $3,334.45 | |
July 5, 2023 | CEO | 2,719 | $2.45 | Sell | $6,661.55 | |
July 5, 2023 | Insider | 355 | $2.45 | Sell | $869.75 | |
Jan. 5, 2023 | COO | 729 | $5.41 | Sell | $3,943.89 | |
Jan. 4, 2023 | Insider | 820 | $5.58 | Sell | $4,575.60 | |
Jan. 4, 2023 | CFO | 1,639 | $5.58 | Sell | $9,145.62 | |
Jan. 3, 2023 | CEO | 32,019 | $5.85 | Sell | $187,311.15 | |
Oct. 18, 2022 | Director | 15,000 | $11.70 | Sell | $175,500.00 | |
Sept. 20, 2022 | Director | 20,000 | $13.50 | Sell | $270,000.00 | |
Sept. 13, 2022 | Insider | 18,000 | $15.71 | Sell | $282,780.00 | |
Aug. 16, 2022 | Director | 80,000 | $12.64 | Sell | $1,011,200.00 | |
July 5, 2022 | COO | 648 | $5.17 | Sell | $3,350.16 | |
Jan. 5, 2022 | General Counsel | 1,445 | $10.61 | Sell | $15,331.45 | |
Jan. 3, 2022 | CEO | 34,125 | $10.41 | Sell | $355,241.25 | |
July 15, 2021 | Director | 10,000 | $18.49 | Sell | $184,900.00 | |
July 13, 2021 | Director | 10,000 | $19.45 | Sell | $194,500.00 | |
June 17, 2021 | Director | 10,000 | $21.77 | Sell | $217,700.00 | |
June 15, 2021 | Director | 10,000 | $22.39 | Sell | $223,900.00 | |
May 13, 2021 | Director | 30,000 | $19.90 | Sell | $597,000.00 | |
May 11, 2021 | Director | 10,000 | $19.10 | Sell | $191,000.00 | |
April 22, 2021 | Insider | 15,000 | $22.07 | Sell | $331,050.00 | |
April 14, 2021 | Director | 10,000 | $24.53 | Sell | $245,300.00 | |
March 23, 2021 | Insider | 15,000 | $21.94 | Sell | $329,100.00 | |
Feb. 18, 2021 | Director | 10,000 | $26.02 | Sell | $260,200.00 | |
Feb. 16, 2021 | Director | 11,040 | $35.20 | Sell | $388,608.00 | |
Jan. 22, 2021 | Insider | 15,000 | $20.64 | Sell | $309,600.00 | |
Jan. 20, 2021 | Director | 10,000 | $21.51 | Sell | $215,100.00 | |
Dec. 24, 2020 | Director | 924 | $20.10 | Sell | $18,572.40 | |
Dec. 22, 2020 | Director | 18,974 | $20.33 | Sell | $385,741.42 | |
Dec. 17, 2020 | CEO | 30,000 | $19.53 | Sell | $585,900.00 | |
Dec. 15, 2020 | CEO | 10,000 | $19.43 | Sell | $194,300.00 | |
Dec. 10, 2020 | Director | 546 | $20.00 | Sell | $10,920.00 | |
Dec. 10, 2020 | SVP | 9,000 | $20.06 | Sell | $180,540.00 | |
Dec. 8, 2020 | Director | 13,161 | $20.19 | Sell | $265,720.59 | |
Dec. 1, 2020 | Director | 520 | $20.09 | Sell | $10,446.80 | |
Nov. 18, 2020 | Director | 50,000 | $13.50 | Buy | $675,000.00 | |
Sept. 4, 2020 | General Counsel | 1,000 | $14.95 | Buy | $14,950.00 | |
Dec. 26, 2018 | General Counsel | 1,000 | $18.25 | Buy | $18,250.00 | |
Dec. 26, 2018 | Director | 1,420 | $18.45 | Buy | $26,199.00 | |
Dec. 17, 2018 | Insider | 3,776 | $30.00 | Sell | $113,280.00 | |
Dec. 10, 2018 | Insider | 1,000 | $33.15 | Buy | $33,150.00 | |
Dec. 6, 2018 | VP | 750 | $34.00 | Sell | $25,500.00 | |
Dec. 4, 2018 | Director | 10,000 | $39.31 | Sell | $393,100.00 |
Insiders are both buying and selling G1 Therapeutics Inc stock.
The insider traders at G1 Therapeutics Inc are: Mark A Velleca, Rajesh Malik, Jennifer K Moses, Seth Rudnick, Terry L Murdock, John E (Jack) Jr. Bailey, Clay Thorp, James S Hanson, Medimmune Ventures, Inc., Andrew Perry, Fredric N Eshelman, John W V Umstead, Mark A. Velleca, Barclay A Phillips, Jay Strum, Ra Capital Healthcare Fund Lp, Glenn P Muir, Cynthia Schwalm, and John Demaree
The most active insider trader at G1 Therapeutics Inc is Mark A Velleca with 19 trades.
Clay Thorp has sold the most G1 Therapeutics Inc stock with a total value of $78,716,625.00.
Fredric N Eshelman has bought the most G1 Therapeutics Inc stock with a total value of $14,365,000.00.
The most recent insider trade for G1 Therapeutics Inc was on March 18, 2024.
The single biggest insider buy for G1 Therapeutics Inc was from Ra Capital Healthcare Fund Lp with a total value of $6,000,000.00 on May 22, 2017.
The single biggest insider sell for G1 Therapeutics Inc was from Clay Thorp with a total value of $38,400,000.00 on May 30, 2018.